CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, a commercial-stage medical technology company and pioneer of the personalized spine surgery market, today announced the successful launch of its state-of-the-art digital production line. This innovative technology will enable the company to deliver its aprevo® personalized spinal fusion implants to hospitals in less than ten days..

加利福尼亚州卡尔斯巴德（商业新闻短讯）--Carlsmed是一家商业舞台医疗技术公司，也是个性化脊柱手术市场的先驱，今天宣布成功推出其最先进的数字生产线。这项创新技术将使该公司能够在不到十天的时间内将其aprevo®个性化脊柱融合植入物交付给医院。。

“This advancement is more than just a technical achievement,” said Mike Cordonnier, Chairman and CEO of Carlsmed. “The reduced lead time makes aprevo® available for surgeries with shorter scheduling windows, increasing addressable procedures and furthering our commitment to making personalized surgery accessible to every patient who needs it.”.

Carlsmed董事长兼首席执行官迈克·科尔登尼尔（MikeCordonnier）表示：“这一进步不仅仅是一项技术成就。”。“缩短的交付周期使aprevo®可用于更短的计划窗口的手术，增加了可寻址的程序，并进一步促进了我们对每个需要个性化手术的患者的承诺。”。

Carlsmed’s current portfolio of patient-specific devices is indicated for use in lumbar spine fusion surgery. The company is developing patient-specific implants for cervical spine fusion surgery and received FDA Breakthrough Device designation for cervical fusions earlier this year. The launch of aprevo® for cervical fusions is expected by the end of 2025..

Carlsmed目前的患者专用设备组合适用于腰椎融合手术。该公司正在开发用于颈椎融合手术的患者专用植入物，并于今年早些时候获得了FDA突破性的颈椎融合装置指定。预计2025年底将推出aprevo®宫颈融合器。。

“The aprevo® implants were crucial for my recovery,” said Renee Schreiner, a patient who received the aprevo® procedure. “When my surgeon told me that personalized spine surgery was available to me, I immediately felt more comfortable choosing to have surgery. Knowing that my implant was designed just for me made all the difference.”.

接受aprevo®手术的患者Renee Schreiner说：“aprevo®植入物对我的康复至关重要。”。“当我的外科医生告诉我可以进行个性化脊柱手术时，我立即感到更舒服地选择手术。知道我的植入物是专门为我设计的，这一切都有所不同。”。

Carlsmed is dedicated to innovation and excellence in personalized healthcare, ensuring that it meets the unique needs of every individual it serves. Clinical publications show significant improvements in patient outcomes for aprevo® personalized procedures compared to traditional spine fusion surgery..

卡尔斯米德致力于个性化医疗保健的创新和卓越，确保它满足其服务的每个人的独特需求。临床出版物显示，与传统脊柱融合手术相比，aprevo®个性化手术的患者预后有了显着改善。。

About Carlsmed

关于Carlsmed

Carlsmed is a commercial stage medical technology company and leader of the personalized spine surgery market. aprevo® is the only commercially available custom made anatomically designed interbody for spine fusion surgery.

Carlsmed是一家商业化的医疗技术公司，也是个性化脊柱手术市场的领导者。aprevo®是唯一可商购的定制解剖学设计的椎体间融合手术。